Immunogenicity of repeated dose 13-valent pneumococcal conjugate vaccine compared to the existing recommended protocol of pneumococcal polysaccharide vaccine in adult kidney and liver transplant patients.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms HUCH; SOT-13
- 18 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Apr 2015 Planned number of patients changed from 150 to 195 as per ClinicalTrials.gov record.
- 31 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01781871).